Related Experiment Videos
[Impact on lymphocyte transformation with BCG different strains vaccination]
1National Institute for the Control of Pharmaceutical and Biological Products, Beijing.
Summary
The D2 strain of BCG vaccination induced a stronger cell-mediated immunity (CMI) response in guinea pigs compared to the D1 strain. This was observed through enhanced lymphocyte proliferation to various stimuli post-vaccination.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Context:
- Bacille Calmette-Guérin (BCG) is a widely used vaccine against tuberculosis.
- Different BCG strains may exhibit varying immunogenic potentials.
- Understanding strain-specific immune responses is crucial for vaccine development.
Purpose:
- To compare the immunogenicity of two BCG strains, D1 and D2, based on lymphocyte transformation assays.
- To evaluate the impact of BCG vaccination on cell-mediated immunity (CMI) in a guinea pig model.
- To determine the optimal time post-vaccination for assessing lymphocyte responses.
Summary:
- Guinea pigs vaccinated with BCG strains D1 or D2, or left unvaccinated, were assessed for spleen lymphocyte transformation.
- Lymphocyte proliferation responses to phytohemagglutinin (PHA), concanavalin A (ConA), and purified protein derivative (PPD) were measured at 3, 4, and 5 weeks post-vaccination.
- The D2 strain elicited significantly higher lymphocyte proliferation to PHA, ConA, and PPD compared to the D1 strain, indicating a stronger CMI response.
Impact:
- The findings suggest that the BCG D2 strain possesses superior ability to elicit cell-mediated immunity compared to the D1 strain.
- This research contributes to the understanding of BCG strain variability and its implications for vaccine efficacy.
- Results may inform future strategies for selecting or developing BCG strains with enhanced immunogenic properties.